ConductScience.org, home

Paper319271

Clinical study of ticrynafen. A new diuretic, antihypertensive, and uricosuric agent.

Nemati M and 2 others. JAMA, 1977. Cited by 55 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Clinical study of ticrynafen. A new diuretic, antihypertensive, and uricosuric agent. Papers, record 319271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/319271

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical study of ticrynafen. A new diuretic, antihypertensive, and uricosuric agent.
PubMed
Journal
JAMA
PubMed
Year
1977
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
55
iCite
Relative citation ratio, by iCite
3.34
iCite
Revised in PubMed
2016-10-17
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nemati MM
2Kyle MCM C
3Freis EDE D

Source PubMed

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
DiureticsMajor topic
GlycolatesMajor topic
HydrochlorothiazideMajor topic
PhenoxyacetatesMajor topic
ThiophenesMajor topic
Uricosuric AgentsMajor topic
Adult
Aged
Blood Pressure
Body Weight
Clinical Trials as Topic
Drug Evaluation
Heart Rate
Humans
Hypertension
Male
Middle Aged
Uric Acid

Source PubMed

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 55 citations.

PMIDTitleJournalYearIn PapersSource
7,711,418Interaction of allopurinol and hydrochlorothiazide during prolonged oral administration of both drugs in normal subjects. I. Uric acid kinetics.Clin Investig1994https://conductscience.org/library/papers/7711418PubMed
7,398,676Binding of Tienilic acid (Diflurex) to human plasma proteins and erythrocytes.Eur J Drug Metab Pharmacokinet1980https://conductscience.org/library/papers/7398676PubMed
7,261,949The risks of asymptomatic hyperuricaemia and the use of uricosuric diuretics.Drugs1981https://conductscience.org/library/papers/7261949PubMed
7,049,708Ticrynafen and hydrochlorothiazide. A comparison in hypertensive patients with renal impairment.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/7049708PubMed
7,009,134Antirheumatic drugs: clinical pharmacology and therapeutic use.Drugs1980https://conductscience.org/library/papers/7009134PubMed
7,004,473Effect of tienilic acid and amiloride in healthy volunteers and in hypertensives with normal renal function.Br J Clin Pharmacol1980https://conductscience.org/library/papers/7004473PubMed
2,714,684Immune mechanisms in tienilic acid associated hepatotoxicity.Gut1989https://conductscience.org/library/papers/2714684PubMed
391,578Multicentre comparative trial of tienilic acid and hydrochlorothiazide in hypertensive patients.Eur J Clin Pharmacol1979https://conductscience.org/library/papers/391578PubMed
25,707Treatment of arterial hypertension with tienilic acid, a new diuretic with uricosuric properties.Can Med Assoc J1978https://conductscience.org/library/papers/25707PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/319271

GET https://conductscience.org/api/papers/v1/319271/authors